Facebook Lung Cancer Drug Market Depth Analysis: EGFR-ALK-ROS1 Inhibitors, PD-1/PD-L1 Checkpoint Inhibitors, and Neoadjuvant-Adjuvant Treatment for NSCLC
Logo

Lung Cancer Drug Market Depth Analysis: EGFR-ALK-ROS1 Inhibitors, PD-1/PD-L1 Checkpoint Inhibitors, and Neoadjuvant-Adjuvant Treatment for NSCLC

クレジット
Avatar
イラストレーター
Lung Cancer Drug Market Depth Analysis: EGFR-ALK-ROS1 Inhibitors, PD-1/PD-L1 Checkpoint Inhibitors, and Neoadjuvant-Adjuvant Treatment for NSCLC-1
シェア
Ciciの他の作品